QHP Capital

Applied StemCell Inc. is a biotechnology company specializing in the development of animal and cell line models for drug discovery and diagnostics. The company utilizes its proprietary TARGATT™ gene modification technology to create site-specific Knockin mouse, rat, and human cell line models, making the process efficient for both pharmaceutical and academic researchers. Applied StemCell's offerings include a range of genetically modified models, such as Knockin, Knockout, and transgenic mice, as well as humanized mouse models and gene-modified induced pluripotent stem cells (iPSCs). In addition to model development, the company provides optimized stem cell culture products and gene engineering services for mammalian cells. By continuously enhancing its technologies and product lines, Applied StemCell aims to meet the evolving needs of the biomedical community and support advancements in molecular diagnostics and personalized medicine.

CoPilot Provider Support Services provides innovative, patient-centric hub, and market-access services to manufacturers.

AutoCruitment is an innovative company that has created an automated platform designed to streamline the recruitment process for clinical trials. By integrating advanced algorithms with an automated system, AutoCruitment addresses the complexities associated with finding and enrolling qualified volunteers for clinical trials. The platform utilizes over 400 online channels to effectively target, recruit, screen, and refer both patients and healthy volunteers for various clinical and medical device trials, spanning Phase I to IV. This approach significantly reduces patient acquisition costs by 75% compared to traditional advertising methods, while simultaneously increasing enrollment rates and accelerating the overall timelines of clinical studies. Through its sophisticated technology, AutoCruitment enhances the efficiency of patient recruitment across diverse therapeutic areas.